548
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer

, , , , , & show all
Pages 472-480 | Received 27 Feb 2014, Accepted 18 Nov 2014, Published online: 24 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alice Avancini, Ilaria Trestini, Daniela Tregnago, Massimo Lanza, Jessica Menis, Lorenzo Belluomini, Michele Milella & Sara Pilotto. (2021) A multimodal approach to cancer-related cachexia: from theory to practice. Expert Review of Anticancer Therapy 21:8, pages 819-826.
Read now
Anne van der Werf, Querijn N. E. van Bokhorst, Marian A. E. de van der Schueren, Henk M. W. Verheul & Jacqueline A. E. Langius. (2018) Cancer Cachexia: Identification by Clinical Assessment versus International Consensus Criteria in Patients with Metastatic Colorectal Cancer. Nutrition and Cancer 70:8, pages 1322-1329.
Read now

Articles from other publishers (27)

Julia Freckelton, Ashray Rajagopalan, Gregory T. Moore & Daniel Croagh. (2024) Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer. Pancreas.
Crossref
Aynur Aktas, Cliona M. Lorton, Oonagh Griffin, Keira Higgins, Fiona Roulston, Gillian Stewart, Niamh Corkery, Elizabeth Barnes & Declan Walsh. (2022) Application of the 2011 international consensus cancer cachexia classification in routine oncology dietetic practice: An observational study. Nutrition in Clinical Practice 38:4, pages 790-797.
Crossref
Mitra Tewes, Freerk Baumann, Martin Teufel & Christoph Ostgathe. (2021) Symptoms During Outpatient Cancer Treatment and Options for their Management. Deutsches Ärzteblatt international.
Crossref
Nicolas Williet, Marion Fovet, Khawla Maoui, Clément Chevalier, Meriem Maoui, Bertrand Le RoyXavier Roblin, Bachir Hag & Jean-Marc Phelip. (2021) A Low Total Psoas Muscle Area Index Is a Strong Prognostic Factor in Metastatic Pancreatic Cancer. Pancreas 50:4, pages 579-586.
Crossref
Thomas K. Sin, Guohua Zhang, Zicheng Zhang, James Z. Zhu, Yan Zuo, Jeffrey A. Frost, Min Li & Yi-Ping Li. (2021) Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300. Cancer Research 81:4, pages 885-897.
Crossref
Aoife M. Ryan & Erin S Sullivan. (2020) Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice. Proceedings of the Nutrition Society 80:1, pages 73-91.
Crossref
Katherine L. Ford, Michael B. Sawyer, Claire F. Trottier, Sunita Ghosh, Nicolaas E.P. Deutz, Mario Siervo, Kathryn N. Porter Starr, Connie W. Bales, Ilana Roitman Disi & Carla M. Prado. (2021) Protein Recommendation to Increase Muscle (PRIMe): Study protocol for a randomized controlled pilot trial investigating the feasibility of a high protein diet to halt loss of muscle mass in patients with colorectal cancer. Clinical Nutrition ESPEN 41, pages 175-185.
Crossref
Emanuelly Varea Maria Wiegert, Livia Costa de Oliveira, Larissa Calixto-Lima, Márcia Soares da Mota e Silva Lopes & Wilza Arantes Ferreira Peres. (2020) Cancer cachexia: Comparing diagnostic criteria in patients with incurable cancer. Nutrition 79-80, pages 110945.
Crossref
Julia Wojzischke, Janneke van Wijngaarden, Claudia van den Berg, Aysun Cetinyurek-Yavuz, Rebecca Diekmann, Yvette Luiking & Jürgen Bauer. (2020) Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. European Geriatric Medicine 11:2, pages 195-207.
Crossref
Anne Gingrich, Dorothee Volkert, Eva Kiesswetter, Marta Thomanek, Svenja Bach, Cornel C. Sieber & Yurdagül Zopf. (2019) Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatrics 19:1.
Crossref
James Bundred, Sivesh K. Kamarajah & Keith J. Roberts. (2019) Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB 21:12, pages 1603-1612.
Crossref
Aoife M. Ryan, Carla M. Prado, Erin S. Sullivan, Derek G. Power & Louise E. Daly. (2019) Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition 67-68, pages 110539.
Crossref
Kevin G. Burfeind, Xinxia Zhu, Peter R. Levasseur, Katherine A. Michaelis, Mason A. Norgard & Daniel L. Marks. (2018) TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. Brain, Behavior, and Immunity 73, pages 364-374.
Crossref
Mohammadamin Sadeghi, Mahsa Keshavarz-Fathi, Vickie Baracos, Jann Arends, Maryam Mahmoudi & Nima Rezaei. (2018) Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology/Hematology 127, pages 91-104.
Crossref
Cynthia Stretch, Jean-Michel Aubin, Beata Mickiewicz, Derek Leugner, Tariq Al-manasra, Elizabeth Tobola, Santiago Salazar, Francis R. Sutherland, Chad G. Ball, Elijah Dixon, Hans J. Vogel, Sambasivario Damaraju, Vickie E. Baracos & Oliver F. Bathe. (2018) Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. PLOS ONE 13:5, pages e0196235.
Crossref
L. E. Daly, C. M. Prado & A. M. Ryan. (2018) A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes. Proceedings of the Nutrition Society 77:2, pages 135-151.
Crossref
Louise E. Daly, Éadaoin B. Ní Bhuachalla, Derek G. Power, Samantha J. Cushen, Karl James & Aoife M. Ryan. (2018) Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. Journal of Cachexia, Sarcopenia and Muscle 9:2, pages 315-325.
Crossref
Louise G Shewan. (2017) An analysis of the types of recently published research in the field of cachexia. European Journal of Preventive Cardiology 24:16, pages 1759-1773.
Crossref
Antonio A.L. Vigano, José A. Morais, Lorella Ciutto, Leonard Rosenthall, Jonathan di Tomasso, Sarah Khan, Henry Olders, Manuel Borod & Robert D. Kilgour. (2017) Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clinical Nutrition 36:5, pages 1378-1390.
Crossref
F. Bozzetti. (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Annals of Oncology 28:9, pages 2107-2118.
Crossref
Susanne Blauwhoff‐Buskermolen, Jacqueline A.E. Langius, Annemarie Becker, Henk M.W. Verheul & Marian A.E. de van der Schueren. (2017) The influence of different muscle mass measurements on the diagnosis of cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle 8:4, pages 615-622.
Crossref
Tomotaka Saito, Kenji Hirano, Hiroyuki Isayama, Yousuke Nakai, Kei Saito, Gyotane Umefune, Dai Akiyama, Takeo Watanabe, Kaoru Takagi, Tsuyoshi Hamada, Naminatsu Takahara, Rie Uchino, Suguru Mizuno, Hirofumi Kogure, Saburo Matsubara, Natsuyo Yamamoto, Minoru Tada & Kazuhiko Koike. (2017) The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer. Pancreas 46:3, pages 341-346.
Crossref
Amelia M. Cullinan. 2017. Pancreatology. Pancreatology 127 149 .
Hánah N. Rier, Agnes Jager, Stefan Sleijfer, Andrea B. Maier & Mark-David Levin. (2016) The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. The Oncologist 21:11, pages 1396-1409.
Crossref
Marco Sandri. (2016) Protein breakdown in cancer cachexia. Seminars in Cell & Developmental Biology 54, pages 11-19.
Crossref
Asta Bye, Nima Wesseltoft-Rao, Per Ole Iversen, Grete Skjegstad, Kirsten B. Holven, Stine Ulven & Marianne J. Hjermstad. (2016) Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer. Medical Oncology 33:6.
Crossref
Henrique A. Parsons, Vickie E. Baracos, David S. Hong, James Abbruzzese, Eduardo Bruera & Razelle Kurzrock. (2016) The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Oncotarget 7:15, pages 20293-20304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.